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Using ‘‘real-time RT-PCR’’, we assessed the expression of three different hyaluronan synthase genes, HAS1, HAS2,
and HAS3, by measuring their mRNA amounts in cultured human oral mucosal epithelial (COME) cells, oral
mucosal ﬁbroblasts, and dermal ﬁbroblasts, and investigated the effects of interleukin-1b (IL-1b) and epidermal
growth factor (EGF). When COME cells were treated with IL-1b or EGF, early and marked increases and subsequent
rapid decreases were observed for all HAS genes and, moreover, actual changes in hyaluronan synthesis
subsequently occurred. The effects of IL-1b stimulation were concentration-dependent and the maximal response
to the EGF stimulation was observed at a low concentration (0.1 ng per mL). When two different types of ﬁbroblasts
were treated with IL-1b or EGF, increased expression with different degrees and rates of three different HAS genes
and subsequent increased synthesis of hyaluronan were also observed. In addition, HAS1 gene expression was not
detectable in the mucosal ﬁbroblasts, while weak HAS3 gene expression was detected in the dermal ﬁbroblasts.
Taken together, it is likely that the regulation of the expression of the three different HAS genes is different between
oral mucosa and skin, which may be of signiﬁcance for elucidating some of the differences between these tissues
in wound healing.
Key words: hyaluronan/hyaluronan synthase genes/real-time RT-PCR analysis/tissue engineering
J Invest Dermatol 122:631 –639, 2004
The process of wound healing depends upon a variety of
interactions between cells and the extracellular matrix
(Clark and Henson, 1988). It is well known that hyaluronan
not only supports tissue architecture as a passive structural
component of the matrix in various connective tissues but is
also involved in dynamic cellular processes such as cell
migration and cell–cell recognition during wound healing
and inflammation (Weigel et al, 1997; Knudson et al, 1989;
Turley, 1989). Three different mammalian hyaluronan
synthases, HAS1, HAS2, and HAS3, have been identified
and characterized (Rosa et al, 1988; Itano and Kimata,
1996a,b; Shyjan et al, 1996; Spicer et al, 1996; Watanabe
and Yamaguchi, 1996; Spicer et al, 1997). The three HAS
genes show distinct expression patterns (Spicer and
Mcdonald, 1998) and the synthases are significantly
different in their enzymatic properties and in their role in
the pericellular hyaluronan coat formation (Itano et al, 1999).
The precise regulatory mechanism of the expression of
each HAS is still unknown. It has been shown that the
synthesis of hyaluronan is stimulated by some growth
regulatory factors and anti-inflammatory cytokines such as
epidermal growth factor (EGF) and IL-1b (Heldin et al, 1989;
Yung et al, 1996; Kaback and Smith, 1999), which have also
been shown to be agents that promote wound healing
(Brown et al, 1986; Gailit et al, 1994). Considering the above
findings on the existence of three different hyaluronan
synthases, it is likely that the expression of each hyaluronan
synthase is regulated in a different manner, depending on
the difference of growth regulatory factors or cytokines.
Langer and Vacanti (1993) described a new technology
for solid organ transplants called tissue engineering, which
involves the morphogenesis of new tissue using constructs
formed from isolated cells cultured with growth regulatory
factors and biocompatible scaffolds. Ueda et al (1995)
fabricated cultured epithelium sheets for skin repair using
cultured human oral mucosal epithelial (COME) cells and
attained good clinical results. Therefore, we focused on the
relationship among the growth regulatory factors, extra-
cellular matrix, and epidermal and dermal cells, with the aim
of tissue regeneration without scarring.
Most skin lesions heal rapidly and efficiently within a
week or two; however, scars remain where the collagen
matrix has been poorly reconstituted. Oral mucosa, on the
other hand, rarely suffers from scarring in the process of
Abbreviations: COME cells, cultured human oral mucosal epithelial
cells; EGF, epidermal growth factor; HA, hyaluronan; hHAS, human
hyaluronan synthase; IL-1b, interleukin-1b; ORF, open reading
frame; PCR, polymerase chain reaction; RT-PCR, reverse tran-
scriptase-polymerase
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wound healing (Tsai et al, 1995) and appears to be different
from skin in this regard. We have developed a method to
fabricate cultured epithelium for skin repair using COME
cells, which are a potential new source of cells for cultured
epithelial grafts without scarring (Ueda et al, 1995). There-
fore, comparison of the regulation of hyaluronan synthesis
in oral mucosa with that in skin may yield important insights
into the wound-healing processes characteristic of oral
mucosa lesions. Histological analysis of the hyaluronan
distribution in skin showed that this molecule is localized
not only in the dermis but also in the epidermis (Tammi et al,
1984). The ability of keratinocytes to synthesize hyaluronan
has been reported in both cell cultures (Brown and
Parkinson, 1983) and organ cultures (Tammi et al, 1989;
Agren et al, 1995). Skin grafts have been shown to promote
wound closure by releasing a variety of cytokines (Krejci
et al, 1991; Martin, 1997). Therefore, it is likely that the
expression of three different hyaluronan synthases in the
skin may be regulated by these factors. Actually, Sugiyama
et al (1998) found that TGF-b upregulates HAS 1 and HAS2
expression independently in cultured human skin fibro-
blasts. Although HAS1, 2, and 3 mRNAs have been
detected in various tissues by northern blot analyses
(Spicer and Mcdonald, 1998), comparative studies on the
distributions of HAS1, 2, and 3 expression as well as on the
effect of cytokines on their expression between oral mucosa
and skin have not yet been performed.
Real-time RT-PCR analysis enables one to detect
quantitatively certain mRNAs in RNA samples, although
careful attention must be paid to establishing suitable PCR
conditions and primers (Gibson et al, 1996; Heid et al,
1996). In this study, we took advantage of this new method
and also developed culture systems to assess the expres-
sion of the HAS1, HAS2, and HAS3 genes and hyaluronan
synthesis in COME cells, oral mucosal fibroblasts, and skin
dermal fibroblasts, and compared them before and after
simulation by IL-1b or EGF. The current results may help to
clarify some of the mechanisms of the different responses in
wound healing between oral mucosa and skin, and define
potential targets for specific therapy directed at modulating
hyaluronan synthesis in tissue engineering.
Results
Stimulation of expression of HAS genes by IL-1b or EGF
in human mucosal COME cells Using real-time RT-PCR
analysis, we measured the absolute amounts of the mRNAs
of the three different hyaluronan synthases, HAS 1, HAS2,
and HAS3, in the COME cells. Comparisons of the
expression among different samples by normalizing each
of the absolute amounts enabled us to elucidate how the
addition of IL-1b or EGF affected the expression of the HAS
1, HAS2, and HAS3 genes. Treatment of COME cells with
0.1–100 ng per mL of IL-1b or EGF for 3 h resulted in a
marked increase in both HAS1 and HAS2 mRNAs (Figs 1
and 2). Maximal levels of HAS1 and HAS2 expression were
attained at 100 ng per mL IL-1b and 0.1 ng per mL EGF,
respectively. Since EGF at this concentration (0.1 ng per
mL) is used as one of the supplements for HuMedia-KG2
medium (commercially available), our finding indicates that
this medium is suitable at least for hyaluronan synthesis by
Figure 1
Stimulation by IL-1b of HAS1 (a), HAS2 (b), and HAS3 (c) gene expression in COME cells. COME cells were cultured in the presence of IL-1b at
the indicated concentrations: 0 ng per mL (m), 0.1 ng per mL (  ), 1 ng per mL (4), 10 ng per mL (  ), and 100 ng per mL (  ). After 3, 6, 12, and
24 h, cells were lysed and total RNA were extracted. Total RNA were also extracted from the cells just before adding IL-1b as a control (0 h). Equal
amounts of total RNA (200 ng) were subjected to real-time RT-PCR analysis, and the absolute amounts of mRNA of HAS1, HAS2, HAS3, and GAPDH
in each sample were quantitated by comparison with their standard curves, as described in Materials and Methods. The expression coefficient for
each mRNA (plotted on the ordinate) was calculated by dividing the absolute amount of each mRNA (HAS1, HAS2, and HAS3) by the absolute
amount of GAPDH mRNA in each sample so that quantitative comparisons of the expression of each HAS mRNA could be made among the different
samples. Each point is the mean value obtained from five independent experiments in which the differences were less than 10%. Significantly
different from the control value; po0.01. Boxed values are also significantly different (po0.01) from the control.
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COME cells. The amounts of HAS1 and HAS2 mRNAs were
increased in a concentration-dependent manner by IL-1b at
all concentrations tested, while those in EGF-treated COME
cells were maximal at 0.1 ng per mL EGF and decreased to
almost the basal level at the higher concentrations of EGF in
order of HAS1 and HAS expression (Fig 3). A much smaller
increase of HAS3 than of HAS1 and HAS2 expression was
observed in the early phase of the stimulation (Figs 1 and 2).
The concentration-dependent changes in HAS3 expression
after IL-1b or EGF stimulation were similar to, but less
marked than, those in HAS1 and HAS2 expression (Fig 3).
Comparisons of expression coefficients at 3 h, when the
maximal stimulation was observed, suggested that the
absolute amount of HAS2 mRNA was about 20-fold that of
HAS1 mRNA, and about 8-fold that of HAS3 mRNA in
COME cells (Figs 1–3). Therefore, the HAS2 mRNA
appeared to be responsible for most of the hyaluronan
synthase expression in the early phase of IL-1b or EGF
stimulation. The proportion of HAS3 mRNA, however,
appeared to become more significant in the late phase of
the stimulation (Figs 1 and 2).
Stimulation of HAS gene expression by IL-1b or EGF in
cultured human oral mucosal and dermal ﬁbro-
blasts We examined the effects of IL-1b or EGF on the
expression of HAS1, HAS2, and HAS3 mRNAs in cultured
oral mucosal fibroblasts and dermal fibroblasts using the
same method. Stimulation of these fibroblasts with 0.1–100
ng per mL IL-1b or EGF for 3 h resulted in a marked increase
of HAS1 mRNA in cultured dermal fibroblasts, HAS2 mRNA
in both dermal and cultured oral mucosal fibroblasts, and
HAS3 mRNA in cultured oral mucosal fibroblasts. Maximal
levels of HAS1 and HAS2 expression were attained at 1 ng
per mL IL-1b in dermal fibroblasts, while those of HAS2
and HAS3 expression were attained at 1 ng per mL EGF in
oral mucosal fibroblasts (Fig 4). Neither significant HAS1
gene expression in cultured oral mucosal fibroblasts nor
HAS3 gene expression in dermal fibroblasts was detected
at any concentration of EGF or IL-1b (Fig 4). Interestingly,
lower expression of the HAS2 gene was observed in both
types of fibroblasts after EGF stimulation compared with
that after IL-1b stimulation, whereas the opposite was
observed in COME cells after EGF and IL-1b stimulation
Figure 2
Stimulation by EGF of HAS1 (a), HAS2 (b),
and HAS3 (c) gene expression in COME
cells. COME cells were cultured in the
presence of EGF at the indicated concen-
trations: 0 ng per mL (m), 0.1 ng per mL (  ),
1 ng per mL (4), 10 ng per mL (  ), and 100
ng per mL (  ). After 3, 6, 12, and 24 h, cells
were lysed and total RNA were extracted.
Total RNA were also extracted from the cells
just before the addition of EGF as a control
(0 h). The ordinate represents the expres-
sion coefficient for each mRNA, which was
calculated as described in Fig 1. Each point
is the mean value obtained from five inde-
pendent experiments in which the differ-
ences were less than 10%. Significantly
different from the control value; po0.01.
Boxed values are also significantly different
(po0.01) from the control.
Figure 3
Comparison of concentration-depen-
dent changes of HAS1 (a), HAS2 (b),
and HAS3 (c) gene expression between
stimulation by IL-1b or EGF. COME cells
were cultured in the presence of the
indicated concentrations of 0.1–100 ng
per mL IL-1b (.) or EGF (,). After 3 h,
cells were lysed and total RNA were
extracted. Total RNA were also extracted
from the cells just before the treatment for
the 0 h sample. Quantitation of each mRNA
(HAS1, HAS2, and HAS3) was performed
using equal amounts of total RNA (200 ng)
by real-time RT-PCR as described in
Materials and Methods. The ordinate repre-
sents the expression coefficient for each
mRNA, which was calculated as described
in Fig 1. Each point is the mean value
obtained from five independent experi-
ments in which the differences were less
than 10%. Significantly different from the
control value; po0.01.
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(compare concentration-dependency in Fig 4 with that in
Fig 3).
We then investigated the upregulation of the expression
of HAS1, HAS2, and HAS3 mRNAs when oral mucosal and
dermal fibroblasts were stimulated with 1 ng per mL IL-1b or
EGF for different periods. Treatment of oral mucosal
fibroblasts with IL-1b or EGF resulted in marked and
moderate increases, respectively, in the amount of HAS2
mRNA, with maximal stimulations at 6 and 3 h, respectively
(Figs 5 and 6). On the other hand, the amount of HAS3
mRNA in mucosal fibroblasts was increased time depen-
dently for at least 24 h by IL-1b stimulation, but reached
a plateau with a 2-fold increase at 3 h in response to
EGF stimulation (Figs 5 and 6). When dermal fibroblasts
were treated with IL-1b or EGF, the upregulation of
expression of HAS1 and HAS2 mRNAs was observed as
early as 3 h after stimulation with either agent. The amount
of HAS1 mRNA, however, was further increased time
dependently up to 12 h, and then decreased to almost the
basal level. The level of HAS2 mRNA was increased to a
maximum at 6 h after IL-1b stimulation, decreased at 12 h,
and again increased slightly thereafter. The maximal HAS2
expression level after IL-1b stimulation in dermal fibroblasts
was 1.5 times higher than that after EGF stimulation
(expression coefficient, 1.45 vs 0.93) (compare Fig 5 with
Fig 6). The maximal stimulations by these cytokines of
HAS1, HAS2, and HAS3 gene expression in both types of
fibroblasts were mostly observed later than those in COME
cells, as described above. The expression coefficients in
Figs 5 and 6 suggest that in both types of cells, HAS2
mRNA was more abundant (about 5-fold) than the other
HAS mRNAs.
These differences suggest that HAS1, HAS2, and HAS3
gene expression in oral mucosal and dermal fibroblasts is
regulated by IL-1b and EGF in distinct manners that are cell-
origin-specific and cytokine-specific.
Figure 4
Comparison of concentration-dependent changes of HAS1 (a), HAS2 (b), and HAS3 (c) gene expression in oral mucosal and dermal
fibroblasts between stimulation by IL-1b or EGF. Oral mucosal fibroblasts and dermal fibroblasts were cultured in the presence of the indicated
concentrations of 0.1–100 ng per mL IL-1b (’ for oral mucosal fibroblasts,& for dermal fibroblasts) or EGF (m for oral mucosal fibroblasts, 4 for
dermal fibroblasts) After 3 h, cells were lysed and total RNA were extracted. Total RNA were also extracted from the cells just before the treatment
for the 0 h sample. Quantitation of each mRNA (HAS1, HAS2, and HAS3) was performed using equal amounts of total RNA (200 ng) by real-time RT-
PCR as described in Materials and Methods. The ordinate represents the expression coefficient for each mRNA, which was calculated as described
in Fig 1. Each point is the mean value obtained from five independent experiments in which the differences were less than 10%. Significantly
different from the control value; po0.01.
Figure5
Comparison of stimulation by IL-1b of
HAS1 (a), HAS2 (b), and HAS3 (c) gene
expression between oral mucosal and
dermal fibroblasts. Oral mucosal (’) and
dermal (&) fibroblasts were cultured in the
presence of 1 ng per mL IL-1b. After 3, 6,
12, and 24 h, cells were lysed and total RNA
were extracted. For controls (0 h sample),
total RNA were also extracted from the cells
just before the addition of IL-1b. Quantita-
tion of each mRNA (HAS1, HAS2, and
HAS3) was performed using equal amounts
of total RNA (200 ng) by real-time RT-PCR
as described in Materials and Methods. The
ordinate represents the expression coeffi-
cient for each mRNA, which was calculated
as described in Fig 1. Each point is the
mean value obtained from five independent
experiments in which the differences were
less than 10%. Significantly different from
the control value; po0.01.
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Time course of IL-1b- or EGF-induced hyaluronan
synthesis in cultured human COME cells, oral mucosal,
and dermal ﬁbroblasts To monitor the rate of hyaluronan
synthesis at different times between 0 and 24 h after
treatment with 1 ng per mL IL-1b or EGF, we measured the
HA concentration in the culture medium at different times by
a competitive ELISA-like assay, as shown in Fig 7. In COME
cell cultures, IL-1b or EGF treatment induced an  2–7-fold
increase of newly synthesized hyaluronan during the
stimulation, compared to the level at 3 h (Fig 7a). The
amounts of HA in the cultures treated with either agent
further increased time dependently up to 24 h. On the other
hand, the amounts of HA in cultures of oral mucosal
fibroblasts treated with IL-1b or EGF showed an  23–47-
fold increase, and that in cultures of dermal fibroblasts
showed a 10–20-fold increase, compared to the levels at 3
and 6 h (Fig 7b, c). It is of note that neither oral mucosal
fibroblasts nor dermal fibroblasts showed an IL-1b- or EGF-
induced increase in hyaluronan synthesis until 6 h and that
higher levels of HA were generated in oral fibroblasts than in
dermal fibroblasts after IL-1b stimulation (Fig 7b), whereas
higher levels of HA were observed in dermal fibroblasts than
in oral mucosal fibroblasts after EGF stimulation (Fig 7c)
Overall, it was interesting to see that the increased
expression levels of HAS after IL-1b or EGF stimulation
resulted in increased rates of HA synthesis, although con-
centration dependency of the increase of HA synthesis by
these agents remains to be determined.
Discussion
A major goal of wound-healing biology is to discover how
skin can be induced to reconstruct damaged parts more
perfectly (Martin, 1997). In this regard, we firstly noted the
previous observation that oral mucosa rarely suffers from
Figure 6
Comparison of stimulation by EGF of
HAS1 (a), HAS2 (b), and HAS3 (c) gene
expression between oral mucosal and
dermal fibroblasts. Oral mucosal (’) and
dermal (&) fibroblasts were cultured in the
presence of 1 ng per mL EGF. After 3, 6, 12,
and 24 h, cells were lysed and total RNA
were extracted. For controls (0 h sample),
total RNA were also extracted from the
cells just before the addition of EGF.
Quantitation of each mRNA (HAS1, HAS2,
and HAS3) was performed using equal
amounts of total RNA (200 ng) by real-time
RT-PCR as described in Materials and
Methods. The ordinate represents the ex-
pression coefficient for each mRNA, which
was calculated as described in Fig 1. Each
point is the mean value obtained from five
independent experiments in which the differe-
nces were less than 10%. Significantly
different from the control value; po0.01.
Figure 7
Time course of hyaluronan synthesis after the addition of IL-1b or EGF to COME cells (a), and after the stimulation of oral mucosal (’) and
dermal fibroblasts (&) by IL-1b (b) or EGF (c). HA concentrations of the conditioned media of 3, 6, 12, and 24 h cultures were measured by a
competitive ELISA-like assay as described in Materials and Methods. Each value was calculated by subtracting the control value from the sample
value. The control HA activities were about 14.3 (ng per mL 104 cells) in COME cells (a), 93.6 (ng per mL 104 cells) in oral mucosal fibroblasts, 115 (ng
per mL 104 cells) in dermal fibroblasts, and these values varied only slightly at different times (3, 6, 12, and 24 h). (a) COME cells were cultured in the
presence of 1 ng per mL IL-1b or EGF (b) Oral mucosal and dermal fibroblasts were cultured in the presence of 1 ng per mL IL-1b. (c) Oral mucosal
and dermal fibroblasts were cultured in the presence of 1 ng per mL EGF. Each column represents the mean  SD of three separate experiments.
Significantly different from the value at 3 h; po0.01.
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scarring in the process of wound healing and appears to be
different from skin (Tsai et al, 1995), and therefore focused
on differences in physiological responses to wound healing
between oral mucosa cells and skin cells in this study.
Wound healing involves many dynamic cellular processes,
such as cell proliferation, cell migration, cell–cell interaction,
and inflammation (Martin, 1997). It has been found that
hyaluronan is deeply involved in these dynamic cellular
processes during wound healing and inflammation (Knud-
son et al, 1989; Turley, 1989; Weigel et al, 1997). It is also
known that some cell growth factors and cytokines facilitate
wound healing and re-epithelialization by stimulating kera-
tinocyte proliferation and migration (Clark and Henson,
1988; Gailit et al, 1994; Hubner et al, 1996; Martin, 1997;
Tammi and Tammi, 1998; Pienimaki et al, 2001). Therefore,
in this study we examined the relationships between
hyaluronan synthesis and cellular responses to two cell
growth regulatory factors involved in wound healing of the
skin, namely IL-1b and EGF.
The present results demonstrated that the expression of
the three different HAS genes was increased in COME cells
by IL-1b or EGF treatment, and there was a corresponding
increase of hyaluronan synthesis in these cells after the
treatments. Therefore, such treatments may induce
changes in the extracellular environment via the increased
synthesis and accumulation of hyaluronan. The present
data also showed that the stimulations varied with different
concentrations and times of treatment with the cytokines
and that the stimulation patterns were highly dependent
upon cell origins. This may be important for understanding
the difference in wound healing between oral mucosal
epithelium and epidermis.
Our present study did not focus on human keratinocytes,
because they have already been studied in detail in a few
studies, with the following results. Sugiyama et al (1998)
showed that human keratinocytes expressed HAS1 mRNA
and a trace of HAS2 mRNA, and that when the culture was
stimulated with TGF-b, HAS1 mRNA in keratinocytes was
upregulated but HAS2 mRNA was not. A more recent study
by Pienimaki et al (2001) showed that HAS2 mRNA was
expressed in a rat keratinocyte cell line and EGF stimulation
brought about an increase in HAS2 mRNA corresponding to
about a 30-fold enhancement of hyaluronan production
from the basal synthesis rate. They also showed that there
was no increase in HAS1 or HAS3 in the cell line, but HAS2
mRNA increased 2–3-fold with less than 2 h following
stimulation with EGF. Our present study on oral mucosal
epithelium cells, however, demonstrated that in those cells
the expression of HAS1 and HAS3 was upregulated after
EGF stimulation, although these mRNAs were expressed at
lower levels than HAS2 mRNA, and, in addition, HAS2
mRNA increased 2–11-fold depending on the concentration
of the inducing agent (Fig 3). This finding may have
depended on our use of the different cells or of the real-
time RT-PCR method, which is more accurate than the
methods used in earlier studies. Our finding also suggests
that HAS1 and HAS3 might have distinctive effects on the
wound healing of oral mucosal epithelia.
Sugiyama et al (1998) demonstrated that when human
dermal fibroblasts were stimulated with TGF-b, both HAS1
and HAS2 mRNAs were upregulated. Zhang et al (2000)
found by a quantitative study of HAS mRNA level that no
HAS3 mRNA was detected in the RNA from human skin
fibroblasts. We obtained similar results by quantitative real-
time RT-PCR in our culture system of human dermal
fibroblasts (Fig 4), although we used different cytokines.
Our present study showed for the first time that HAS3 gene
expression was detected in all of the mRNA samples
obtained from human mucosal fibroblasts, but HAS1 gene
expression was not detected. This unique HAS expression
pattern of mucosal fibroblasts may be related to the unique
feature of the lack of scarring in wound healing of oral
mucosa epithelia.
It was interesting that the gradual increase in the amount
of hyaluronan after the rapid and temporal increases in HAS
mRNA expression after IL-1b or EGF treatment and the
rates of hyaluronan synthesis differed, depending on the cell
type and the stimulation agent (Fig 7). There have been
several reports showing that the mRNA levels correlated
with the levels of HAS proteins and with the production of
hyaluronan (Jacobson et al (2000) for human mesothelial
cells; Pienimaki et al (2001) for rat epidermal keratinocytes;
Sayo et al (2002) for human keratinocytes). Pienimaki et al
(2001) showed that the changes in HAS mRNA and
hyaluronan synthesis levels showed a temporal correlation,
suggesting tight transcriptional regulation of hyaluronan
synthesis. In our study, however, in COME cells the
hyaluronan synthetic rates increased gradually and time
dependently with the maximal stimulation of the HAS mRNA
expression at 3 h after IL-1b or EGF treatment, and the rate
induced by IL-1b was higher than that induced by EGF. In
both oral mucosal and dermal fibroblasts, the increased
rates of hyaluronan synthesis were observed at later phases
(12–24 h) than those of the mRNA expression. These
differences suggest that the increased HAS enzyme
proteins translated from the transiently increased amounts
of the mRNAs resulting from the stimulation may have a
long life span and produce hyaluronan continuously,
especially in the cells stimulated by IL-1b. In addition, the
turnover rates of the HAS mRNA may differ, depending on
the cell type and way of stimulating the cells. In relation to
the latter possibility, the gene structures, especially in the
regulatory regions influencing the mRNA turnover, are
different among the three HASs (Spicer and McDonald,
1998), and we previously characterized the promoter region
of the mouse HAS1 gene (Yamada et al, 1998). Investigation
of the respective promoter sequences and identification of
potential enhancer sequences for the three HAS genes and
the respective stability of those HAS mRNAs will be
necessary for understanding the differences in the re-
sponses of the genes to stimulation by various factors.
Jacobson et al (2000) pointed out that the cytokine
inducibility of the transcripts of the three HAS genes might
be widespread, but differ depending on the cell type. Heldin
et al (1989) also showed that cytokines and growth factors
regulate the rates of hyaluronan synthesis differently,
depending on the cell type. Since there were differences
in the experimental systems and conditions, exact compar-
isons between studies cannot be made. There are several
examples, however, in previous reports suggesting that the
above possibility is true. For example, Kaback et al (1999)
showed substantial upregulation of hyaluronan synthesis in
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orbital fibroblasts when they were activated with IL-1b.
Hyaluronan synthesis in human synovial lining cells is
stimulated by TGF-b and IL-1b, and to a lesser extent by
TNF-a, and these cytokines have been suggested to be
major factors leading to the development of joint swelling in
inflammatory and degenerative joint diseases (Tammi and
Tammi, 1998). In human keratinocytes, interferon-g mark-
edly upregulates HAS3 mRNA, whereas transforming
growth factor b downregulates HAS3 transcript levels (Sayo
et al, 2002). We found that in COME cells stimulated by IL-
1b or EGF, there was a smaller increase of HAS3 expression
compared to HAS1 and HAS2 expression at an early phase
of the stimulation (Figs 1 and 2). Human peritoneal
mesothelial cells also show a pronounced increase in
hyaluronan synthesis upon IL-1b stimulation, and the
resultant increase in the hyaluronan level in the peritoneal
cavity was suggested to be relevant to the inflammation in
peritonitis (Yung et al, 1996). In the mesothelial cells, the
IL-1b stimulation caused a continuous time-dependent
increase in hyaluronan synthesis, which appeared to be
different from our present results demonstrating rapid and
temporary stimulation of the expression of all of the HAS
genes by IL-1b (Figs 1, 3, and 5). The effect of EGF on the
hyaluronan synthesis in human foreskin fibroblasts did not
show a sharp dependency on the EGF concentration
(Heldin et al, 1989), but we found that the effect on HAS
mRNA expression in oral mucosal fibroblasts and dermal
fibroblasts did (Fig 4). Taken together, these facts imply that
it is likely that different regulatory mechanisms for the
expression of each of the three HAS genes and the stability
of their transcripts control hyaluronan synthesis in different
cells, which might lead to important differences in the
physiological responses between oral mucosa cells and
skin cells.
The general tendency for EGF to inhibit terminal
differentiation and the ability of EGF to increase the
synthesis of hyaluronan, which we observed in the present
experiments, may be in accord with the previous results on
the treatment of keratinocytes with hydrocortisone (Agren
et al, 1995) and retinoic acid (Tammi et al, 1989), further
strengthening the concept that enhanced hyaluronan
synthesis is associated with the delayed cornification of
keratinocytes and subsequent epidermal thickening (Clark
and Henson, 1988; Tammi and Tammi, 1998). Therefore,
regulating hyaluronan synthesis by using the cytokines EGF
or IL-1b might be useful for adjusting the levels of
hyaluronan in skin cells to levels equal to those in oral
mucosal cells, and might thereby promote wound healing
without scarring in the skin if this is applied to tissue
engineering technology using living cells, cytokines, and
growth factors.
Materials and Methods
Cell culture and RNA isolation Skin and oral mucosa (super-
fluous tissue obtained during surgery) were obtained from five
patients treated in the Department of Oral Surgery and Plastic
Surgery, Nagoya University Hospital. Donors gave informed consent.
The cells were isolated by the method of Hata et al (1995). COME
cells were routinely grown in HuMedia-KG2 medium (Kurabo, Osaka,
Japan) (Boyce et al, 1983), supplemented with insulin (10 mg per mL),
hydrocortisone (0.5 mg per mL), 4% (v/v) bovine pituitary extract, and
EGF (0.1 ng per mL) plus various antibiotics.
To study the effects of IL-1b and EGF, COME cells were
expanded by culturing in HuMedia-KG2 medium with the above
supplements for 5 d. The cells were thoroughly washed with the
medium without the supplements, dissociated by treatment with
trypsin, and inoculated into plastic tissue culture dishes (35 mm)
containing fresh medium at a density of 5.0  105 cells in the
medium without EGF. At 48 h, the medium was exchanged and IL-
1b or EGF (0.1–100 ng per mL) was added to the medium, and the
cells were continuously cultured for the indicated times (0, 3, 6, 12,
and 24 h). Total RNAs were extracted from the cells with an
RNeasy Mini Kit (QIAGEN, GmbH, Hiden, Germany).
Human oral mucosal and dermal fibroblasts were grown in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco Laboratories,
Rockville, MD) containing 10% (v/v) fetal bovine serum and various
antibiotics. In order to make the culture conditions identical to
those used for studies on the stimulation of COME cells by IL-1b or
EGF, the cells were grown for 14 d, dissociated with trypsin, and
inoculated into plastic culture dishes (35 mm in diameter) at a
density of 5.0  105 cells with HuMedia-KG2 medium as described
above. At 48 h, the medium was refreshed and IL-1b or EGF was
added to the medium at 0.1–100 ng per mL. The cells were then
cultured for 0, 3, 6, 12, and 24 h and total RNAs were extracted as
described above.
Preparation of absolute amounts of HAS1, HAS2, and HAS3
mRNAs Samples containing known amounts of HAS1, HAS2, and
HAS3 RNAs were prepared for absolute comparison by real-time
RT-PCR analysis. HAS1 cDNA was prepared as described
previously (Itano and Kimata, 1996b). HAS2 and HAS3 cDNAs
were obtained by PCR with the following pairs of primers—
dGTGTTATACATGTCGAGTTTACTTCC (position 1475–1496 of the
human HAS2 ORF sequence) and dGTCATATTGTTGTCCCTTC-
TTCCGC (position 1789–1766), and dGGTACCATCAGAAGTTCC-
TAGGCAGC (position 83–108 of the human HAS3 ORF sequence)
and dGAGGAGAATGTTCCAGATGCG (position 411–391), respec-
tively—and subcloned into pBluescript II KS vector (Promega,
Madison, Wisconsin). The PCR amplification was carried out by 35
cycles of incubation, with each cycle consisting of denaturation at
941C for 20 s, annealing at 581C for 30 s, and extension at 681C for
8 min. The PCR products were checked by electrophoresis on a
2% (w/v) agarose gel. The cDNAs were confirmed by sequencing
these products. The DNAs containing the respective HAS cDNAs
downstream of the T7 promoter were constructed and used as
templates to synthesize RNAs in vitro by incubation with T7 RNA
polymerase (Boehringer, Mannheim, Germany) according to the
manufacturer’s protocol. The RNAs were purified with an RNeasy
Mini Kit (QIAGEN). The concentration of each RNA sample was
determined by measuring the absorption (A260) with a spectro-
photometer.
Real-time RT-PCR analysis Real-time RT-PCR analysis was
performed according to the reported method (Gibson et al, 1996;
Heid et al, 1996). Briefly, within a gene-specific PCR oligonucleo-
tide primer pair, an oligonucleotide probe labeled with a reporter
fluorescent dye (FAM) at the 50-end and a quencher fluorescent
dye (TAMURA) at the 30-end was designed. When the probe was
intact, the reporter dye emission was quenched. During the
extension phase of the PCR cycle, the nucleolytic activity of the
DNA polymerase cleaved the hybridization probe and released the
reporter dye from the probe. Fluorescence intensity produced
during PCR amplifications was monitored by a sequence detector
directly in the reaction tube (‘‘real time’’). A computer algorithm
compared the amount of reporter dye emission with the quenching
dye emission and calculated the threshold cycle number (CT) when
signals reached ten times the standard deviation of the baseline,
from which the levels of the mRNAs transcribed from the various
genes tested were obtained (Gibson et al, 1996).
Total RNA samples (200 ng of each) were added to a 50 mL RT-
PCR reaction (PCR-Access, Promega). The ‘‘reaction master
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mixture’’ was prepared according to the manufacturer’s protocol to
give final concentrations of 1  avian myeloblastosis virus Tfl
reaction buffer, 0.2 mM dNTPs, 1.5 mM MgSO4, 0.1 U per mL avian
myeloblastosis virus reverse transcriptase, 0.1 U per mL Tfl DNA
polymerase, 250 nM concentration of the primers, and 200 nM
concentration of the corresponding probe, as described by Gibson
et al (1996). Primers and probes for real-time PCR analysis of the
hHAS1, hHAS2, and hHAS3 mRNAs were designed using the Oligo
version 4.0 program (National Bioscience, Plymouth, Minnesota)
according to Heid et al (1996). It has been shown that two or three
transcripts that might be generated using alternative polyadenyla-
tion signals in the 30-untranslated region exist for every HAS mRNA
(Spicer and McDonald, 1998). In addition, there were differences in
the 50-terminal region sequence between the human HAS1 cDNAs
cloned by us (Itano and Kimata, 1996b) and by Shyjan et al (1996).
Therefore, this was taken into consideration when we designed the
combinations of the primers. The sequences of all oligonucleotides
used are shown in Table I. For the hHAS1 mRNA analysis, the
primers hHAS1 900F and hHAS1 1072R were used and the probe
was hHAS1TaqMan FP. For hHAS2 mRNA analysis, the primers
hHAS2 1475F and hHAS2 1789R were used and the probe was
hHAS2 TaqMan FP. For hHAS3 mRNA analysis, the primers hHAS3
83F and hHAS3 411R were used and the probe was hHAS3
TaqMan FP. The GAPDH primer and probe (TaqMan GAPDH
detection reagents) were purchased from Perkin-Elmer and
Applied Biosystems, Foster City, CA. RT-PCR reactions and the
resulting relative increases in reporter fluorescent dye emissions
were monitored in real time using a 7700 sequence detector
(Perkin-Elmer). Signals were analyzed using the sequence detector
1.0 program (Perkin-Elmer). The conditions for PCR were as
follows: an initial incubation at 501C for 2 min, at 601C for 30 min,
and at 951C for 5 min, followed by 50 cycles of incubation at 951C
for 20 s and 601C for 1 min.
The absolute amount of each HAS mRNA in a given sample was
obtained by comparison with the respective standard curves.
Standard curves for each HAS mRNA were obtained using human
heart t-RNA (Clontech, Palo Alto, California) with different
concentrations (4000, 2000, 1000, 500, 250, 125, and 62.5 ng).
Comparisons of the absolute amount of each mRNA for the three
different HAS synthases among the different samples were made
by using factors that were obtained by dividing the absolute
amount of each mRNA by that of the GAPDH mRNA in each
sample, and were designated as expression coefficients in this
study.
Determination of HA concentrations by competitive ELISA-like
assay Exponentially growing cells were cultured in fresh medium
for 3, 6, 12, or 24 h, and the conditioned medium was recovered
from each culture. The HA content of the conditioned medium was
measured by a competitive ELISA-like assay as described
previously (Itano et al, 1999). Briefly, the conditioned medium
was mixed with biotinylated HA binding protein (b-HABP) and
incubated at 41C for 20 h. The mixture was added to the HA-
coated wells of 96-well plates, followed by incubation for 6 h at
room temperature. Alkaline phosphatase-conjugated streptavidin
was used as the secondary probe, and the enzymatic activity was
measured by using p-nitrophenyl phosphate as the substrate. HA
contents were calculated by using a standard curve.
Statistical analysis The Dunnett test was used for comparisons
between control and experimental groups (Dunnett, 1964).
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